Overview

Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The survey is conducted to collect safety and effectiveness information in Hypertensive patients treated with Micombi Tablets on the long term use in daily clinical settings in Japan.
Details
Lead Sponsor:
Boehringer Ingelheim
Collaborator:
Astellas Pharma Inc
Treatments:
Hydrochlorothiazide
Telmisartan